A Study of ASP1941 in Participants With Type 2 Diabetes Mellitus

NCT00621868 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

361

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: ipragliflozin
DRUG: Placebo

Sponsor

Astellas Pharma Inc